Clinical Study to Evaluate the Efficacy and Safety of Huperzine A Controlled-Release Tablets in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type
Clinical trial NCT07066826 · RECRUITING
Trial details
- NCT number
- NCT07066826
- Sponsor
- Wanbangde Pharmaceutical Group Co., LTD
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-29
- Primary completion
- 2028-08-15
- Enrollment
- 720
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.